Esnani, Saina .
HRN: 07-20-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2026
CEFUROXIME 500MG (TAB)
06/04/2026
06/11/2026
PO
500
Bid
Mastitis
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes